Index RUT
P/E -
EPS (ttm) -2.88
Insider Own 4.34%
Shs Outstand 49.12M
Perf Week 7.07%
Market Cap 5.35B
Forward P/E -
EPS next Y -1.31
Insider Trans -22.41%
Shs Float 48.01M
Perf Month 13.17%
Income -140.87M
PEG -
EPS next Q -0.51
Inst Own 101.32%
Short Float 6.85%
Perf Quarter 15.85%
Sales 326.43M
P/S 16.38
EPS this Y 3.83%
Inst Trans 1.35%
Short Ratio 6.39
Perf Half Y 53.41%
Book/sh 9.04
P/B 11.78
EPS next Y 40.09%
ROA -14.78%
Short Interest 3.29M
Perf Year 129.26%
Cash/sh 5.44
P/C 19.59
EPS next 5Y 8.00%
ROE -29.37%
52W Range 45.47 - 108.22
Perf YTD 34.00%
Dividend Est. -
P/FCF -
EPS past 5Y -49.95%
ROI -16.89%
52W High -1.58%
Beta 1.06
Dividend TTM -
Quick Ratio 4.68
Sales past 5Y 12.76%
Gross Margin 88.32%
52W Low 134.25%
ATR (14) 4.17
Dividend Ex-Date -
Current Ratio 5.38
EPS Y/Y TTM 1.43%
Oper. Margin -32.36%
RSI (14) 69.04
Volatility 5.58% 3.87%
Employees 907
Debt/Eq 0.85
Sales Y/Y TTM 12.92%
Profit Margin -43.16%
Recom 1.67
Target Price 108.88
Option/Short Yes / Yes
LT Debt/Eq 0.85
EPS Q/Q -13.90%
Payout -
Rel Volume 0.66
Prev Close 105.03
Sales Surprise 7.56%
EPS Surprise -21.30%
Sales Q/Q 15.86%
Earnings May 01 AMC
Avg Volume 514.89K
Price 106.51
SMA20 7.81%
SMA50 14.62%
SMA200 33.16%
Trades
Volume 297,644
Change 1.41%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-21-23 Upgrade
JP Morgan
Neutral → Overweight
$66 → $91
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$65
Nov-28-23 Initiated
Truist
Buy
$88
Nov-08-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$75 → $83
Jun-07-23 Upgrade
Piper Sandler
Neutral → Overweight
$55 → $80
Dec-22-22 Initiated
Mizuho
Neutral
$48
Dec-19-22 Upgrade
JP Morgan
Underweight → Neutral
$48 → $42
Dec-12-22 Upgrade
Citigroup
Neutral → Buy
$57
Oct-14-22 Resumed
Stephens
Overweight
$69
Oct-04-22 Initiated
Needham
Buy
$66
Jul-12-22 Upgrade
Stifel
Hold → Buy
$40 → $60
Feb-03-22 Upgrade
William Blair
Mkt Perform → Outperform
Jan-19-22 Upgrade
Wells Fargo
Underweight → Equal Weight
$56
Jan-18-22 Upgrade
BTIG Research
Neutral → Buy
$61
Nov-03-21 Upgrade
Stephens
Equal-Weight → Overweight
$68
Jul-26-21 Downgrade
Stephens
Overweight → Equal-Weight
$70
Jul-20-21 Downgrade
Wells Fargo
Equal Weight → Underweight
$41
Jul-14-21 Downgrade
William Blair
Outperform → Mkt Perform
Jul-14-21 Downgrade
Oppenheimer
Outperform → Perform
Apr-08-21 Upgrade
Oppenheimer
Perform → Outperform
$100
Show Previous Ratings
May-02-24 12:01PM
11:59AM
09:14AM
07:12AM
(Thomson Reuters StreetEvents)
03:38AM
11:53PM
Loading…
May-01-24 11:53PM
05:50PM
05:35PM
04:50PM
(Associated Press Finance)
04:05PM
Apr-16-24 04:05PM
Apr-15-24 08:19AM
Apr-12-24 09:22AM
Apr-10-24 07:00AM
Apr-08-24 10:41AM
12:02PM
Loading…
Apr-04-24 12:02PM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
Mar-22-24 11:30AM
Mar-13-24 07:56AM
Feb-27-24 02:03AM
Feb-22-24 10:16AM
08:58AM
07:47AM
(Thomson Reuters StreetEvents)
Feb-21-24 05:20PM
04:35PM
04:17PM
(Associated Press Finance)
04:05PM
Feb-15-24 02:04AM
Feb-14-24 10:00AM
08:15AM
Loading…
08:15AM
Feb-01-24 03:01PM
Jan-31-24 07:00AM
Jan-30-24 10:42AM
Jan-18-24 07:57PM
Jan-16-24 07:41AM
Jan-11-24 11:26AM
Jan-09-24 07:00AM
Dec-23-23 01:01AM
Dec-21-23 01:31AM
Dec-20-23 07:00AM
Dec-19-23 01:28PM
Dec-18-23 09:49AM
Dec-15-23 05:57AM
Dec-14-23 07:45AM
07:00AM
Dec-03-23 10:30AM
Dec-01-23 11:31AM
Nov-15-23 08:00AM
Nov-07-23 07:00AM
Nov-02-23 06:17PM
10:34AM
Nov-01-23 07:00PM
06:07PM
04:57PM
(Associated Press Finance)
04:05PM
Oct-31-23 07:33AM
07:00AM
Oct-11-23 07:00AM
Oct-05-23 07:53AM
Sep-19-23 06:20AM
Aug-23-23 07:00AM
Aug-03-23 11:16AM
Aug-02-23 10:00PM
06:05PM
04:58PM
(Associated Press Finance)
04:05PM
Aug-01-23 09:02AM
Jul-31-23 06:05PM
Jul-20-23 07:19AM
Jul-19-23 12:43PM
Jul-17-23 07:00AM
Jul-14-23 06:22PM
08:38AM
Jul-12-23 07:00AM
Jun-21-23 08:00PM
Jun-05-23 07:00AM
May-28-23 10:30AM
May-24-23 07:00AM
May-19-23 09:17AM
May-05-23 04:05PM
May-04-23 07:13AM
May-03-23 06:45PM
05:36PM
04:05PM
May-01-23 07:00AM
Apr-26-23 08:00PM
Apr-19-23 07:00AM
Apr-17-23 10:50AM
Apr-12-23 07:00AM
Apr-06-23 05:33AM
Apr-03-23 11:29AM
Feb-27-23 07:27AM
07:00AM
Feb-24-23 05:52AM
Feb-23-23 10:23AM
Feb-22-23 05:55PM
04:05PM
Feb-21-23 10:06AM
Feb-15-23 07:00AM
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hoffmeister David F Director Apr 10 '24 Option Exercise 7.28 10,000 72,750 15,767 Apr 12 07:49 PM Gilliam Joseph E PRESIDENT & COO Apr 08 '24 Option Exercise 41.69 59,801 2,493,104 161,646 Apr 10 08:20 PM Gilliam Joseph E PRESIDENT & COO Apr 08 '24 Sale 100.47 59,801 6,008,359 101,845 Apr 10 08:20 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 08 '24 Sale 100.54 1,372 137,944 52,532 Apr 09 07:46 PM Gilliam Joseph E PRESIDENT & COO Apr 05 '24 Option Exercise 55.18 2,457 135,577 104,302 Apr 09 07:40 PM Gilliam Joseph E PRESIDENT & COO Apr 05 '24 Sale 96.81 2,457 237,862 101,845 Apr 09 07:40 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 05 '24 Sale 96.63 262 25,316 53,904 Apr 09 07:46 PM Gilliam Joseph E PRESIDENT & COO Apr 04 '24 Option Exercise 55.18 200 11,036 102,045 Apr 05 06:15 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 04 '24 Sale 95.33 434 41,371 54,166 Apr 05 06:13 PM Gilliam Joseph E PRESIDENT & COO Apr 04 '24 Sale 96.57 200 19,314 101,845 Apr 05 06:15 PM Gilliam Joseph E PRESIDENT & COO Apr 03 '24 Option Exercise 55.18 200 11,036 102,045 Apr 05 06:15 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 94.62 316 29,900 54,600 Apr 05 06:13 PM Gilliam Joseph E PRESIDENT & COO Apr 03 '24 Sale 96.61 200 19,322 101,845 Apr 05 06:15 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Apr 02 '24 Sale 90.37 474 42,835 54,916 Apr 03 08:32 PM Kliman Gilbert H Director Mar 07 '24 Option Exercise 32.00 5,000 160,000 35,620 Mar 08 05:12 PM Kliman Gilbert H Director Mar 07 '24 Sale 88.25 5,000 441,250 30,620 Mar 08 05:12 PM Kliman Gilbert H Director Mar 06 '24 Sale 85.34 8,347 712,307 0 Mar 08 05:12 PM Stapley Marc Director Feb 29 '24 Option Exercise 32.00 6,250 200,000 38,610 Mar 04 08:09 PM Stapley Marc Director Feb 29 '24 Sale 90.09 6,250 563,087 32,360 Mar 04 08:09 PM Kliman Gilbert H Director Feb 27 '24 Sale 92.00 8,000 736,000 8,347 Feb 29 05:52 PM Gilliam Joseph E PRESIDENT & COO Feb 23 '24 Option Exercise 39.82 118,831 4,731,666 238,633 Feb 27 09:29 PM Foley Mark J Director Feb 23 '24 Option Exercise 7.28 10,000 72,750 37,780 Feb 26 07:01 PM Gilliam Joseph E PRESIDENT & COO Feb 23 '24 Sale 92.14 140,245 12,922,002 98,388 Feb 27 09:29 PM Foley Mark J Director Feb 23 '24 Sale 92.87 4,560 423,487 33,220 Feb 26 07:01 PM Gilliam Joseph E PRESIDENT & COO Feb 12 '24 Option Exercise 55.18 1,512 83,432 121,314 Feb 14 04:56 PM Gilliam Joseph E PRESIDENT & COO Feb 12 '24 Sale 96.80 1,512 146,362 119,802 Feb 14 04:56 PM Gilliam Joseph E PRESIDENT & COO Feb 09 '24 Option Exercise 55.18 631 34,819 120,433 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 09 '24 Sale 96.70 631 61,018 119,802 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 08 '24 Option Exercise 39.10 5,000 195,500 124,802 Feb 12 06:41 PM Gilliam Joseph E PRESIDENT & COO Feb 08 '24 Sale 96.07 5,000 480,350 119,802 Feb 12 06:41 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Feb 08 '24 Sale 95.78 550 52,682 54,035 Feb 09 06:33 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Feb 07 '24 Sale 95.00 33 3,135 54,585 Feb 09 06:33 PM Gilliam Joseph E PRESIDENT & COO Jan 29 '24 Option Exercise 39.10 9,476 370,512 129,278 Jan 31 05:35 PM Gilliam Joseph E PRESIDENT & COO Jan 29 '24 Sale 94.12 9,476 891,881 119,802 Jan 31 05:35 PM Gilliam Joseph E PRESIDENT & COO Jan 22 '24 Option Exercise 39.10 524 20,488 120,326 Jan 24 06:04 PM Gilliam Joseph E PRESIDENT & COO Jan 22 '24 Sale 94.01 524 49,261 119,802 Jan 24 06:04 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Jan 18 '24 Sale 90.54 583 52,784 54,618 Jan 22 05:30 PM Gilliam Joseph E PRESIDENT & COO Jan 16 '24 Option Exercise 30.92 4,890 151,199 124,692 Jan 18 05:30 PM Gilliam Joseph E PRESIDENT & COO Jan 16 '24 Sale 89.17 4,890 436,041 119,802 Jan 18 05:30 PM Gilliam Joseph E PRESIDENT & COO Jan 12 '24 Option Exercise 30.92 110 3,401 119,912 Jan 16 04:59 PM Gilliam Joseph E PRESIDENT & COO Jan 12 '24 Sale 89.01 110 9,791 119,802 Jan 16 04:59 PM Burns Thomas William CHAIRMAN & CEO Jan 09 '24 Option Exercise 7.28 115 837 55,950 Jan 10 07:14 PM Burns Thomas William CHAIRMAN & CEO Jan 09 '24 Sale 86.85 115 9,988 55,835 Jan 10 07:14 PM Burns Thomas William CHAIRMAN & CEO Jan 08 '24 Option Exercise 7.28 60,000 436,500 115,835 Jan 10 07:14 PM Burns Thomas William CHAIRMAN & CEO Jan 08 '24 Sale 82.55 60,000 4,952,706 55,835 Jan 10 07:14 PM Burns Thomas William CHAIRMAN & CEO Jan 02 '24 Option Exercise 7.28 95,000 691,125 150,835 Jan 03 06:18 PM Burns Thomas William CHAIRMAN & CEO Jan 02 '24 Sale 77.20 95,000 7,334,253 55,835 Jan 03 06:18 PM Burns Thomas William CHAIRMAN & CEO Dec 22 '23 Option Exercise 7.28 1 7 55,836 Dec 22 06:03 PM Burns Thomas William CHAIRMAN & CEO Dec 22 '23 Sale 85.32 1 85 55,835 Dec 22 06:03 PM Gilliam Joseph E PRESIDENT & COO Dec 21 '23 Option Exercise 41.69 25,000 1,042,250 145,001 Dec 22 06:05 PM Burns Thomas William CHAIRMAN & CEO Dec 21 '23 Option Exercise 7.28 79,684 579,701 135,519 Dec 22 06:03 PM Burns Thomas William CHAIRMAN & CEO Dec 21 '23 Sale 85.21 79,684 6,789,874 55,835 Dec 22 06:03 PM Gilliam Joseph E PRESIDENT & COO Dec 21 '23 Sale 84.80 25,000 2,120,062 120,001 Dec 22 06:05 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Dec 21 '23 Sale 85.14 583 49,637 55,242 Dec 22 06:04 PM Burns Thomas William CHAIRMAN & CEO Dec 15 '23 Option Exercise 7.28 60,000 436,500 115,835 Dec 18 08:39 PM Burns Thomas William CHAIRMAN & CEO Dec 15 '23 Sale 80.94 60,000 4,856,448 55,835 Dec 18 08:39 PM Thurman Alex R. SVP & CHIEF FINANCIAL OFFICER Dec 15 '23 Sale 79.80 1,270 101,346 55,825 Dec 18 08:41 PM Stapley Marc Director Dec 14 '23 Option Exercise 16.78 16,250 272,750 47,566 Dec 18 08:40 PM Burns Thomas William CHAIRMAN & CEO Dec 14 '23 Option Exercise 7.28 30,000 218,250 85,835 Dec 18 08:39 PM Burns Thomas William CHAIRMAN & CEO Dec 14 '23 Sale 75.91 30,000 2,277,357 55,835 Dec 18 08:39 PM Stapley Marc Director Dec 14 '23 Sale 75.93 16,250 1,233,875 31,316 Dec 18 08:40 PM Burns Thomas William CHAIRMAN & CEO Oct 02 '23 Option Exercise 7.28 45,000 327,375 99,785 Oct 04 05:50 PM Burns Thomas William CHAIRMAN & CEO Oct 02 '23 Sale 71.98 45,000 3,239,262 54,785 Oct 04 05:50 PM Kliman Gilbert H Director Aug 04 '23 Option Exercise 7.28 10,000 72,750 39,725 Aug 08 04:54 PM Kliman Gilbert H Director Aug 04 '23 Sale 74.56 10,000 745,600 29,725 Aug 08 04:54 PM Burns Thomas William CHAIRMAN & CEO Jul 19 '23 Option Exercise 7.28 200 1,455 674,163 Jul 21 04:23 PM Burns Thomas William CHAIRMAN & CEO Jul 19 '23 Sale 80.01 200 16,002 673,963 Jul 21 04:23 PM Gilliam Joseph E PRESIDENT & COO Jul 14 '23 Option Exercise 38.36 42,099 1,615,032 162,583 Jul 18 09:59 PM Burns Thomas William CHAIRMAN & CEO Jul 14 '23 Option Exercise 7.28 30,000 218,250 703,963 Jul 18 08:42 PM Gilliam Joseph E PRESIDENT & COO Jul 14 '23 Sale 78.34 42,099 3,298,036 120,484 Jul 18 09:59 PM Burns Thomas William CHAIRMAN & CEO Jul 14 '23 Sale 77.95 30,000 2,338,427 673,963 Jul 18 08:42 PM Gilliam Joseph E PRESIDENT & COO Jul 12 '23 Option Exercise 41.69 2,700 112,563 123,184 Jul 14 04:21 PM Gilliam Joseph E PRESIDENT & COO Jul 12 '23 Sale 73.09 2,700 197,343 120,484 Jul 14 04:21 PM Burns Thomas William CHAIRMAN & CEO Jul 10 '23 Option Exercise 7.28 13,440 97,776 687,403 Jul 11 07:59 PM Burns Thomas William CHAIRMAN & CEO Jul 10 '23 Sale 70.87 13,440 952,480 673,963 Jul 11 07:59 PM Burns Thomas William CHAIRMAN & CEO Jul 07 '23 Option Exercise 7.28 133 968 674,096 Jul 11 07:59 PM Burns Thomas William CHAIRMAN & CEO Jul 07 '23 Sale 70.00 133 9,310 673,963 Jul 11 07:59 PM Burns Thomas William CHAIRMAN & CEO Jul 05 '23 Option Exercise 7.28 5,027 36,571 678,990 Jul 06 05:01 PM Burns Thomas William CHAIRMAN & CEO Jul 05 '23 Sale 70.02 5,027 351,991 673,963 Jul 06 05:01 PM Burns Thomas William CHAIRMAN & CEO Jul 03 '23 Option Exercise 7.28 26,400 192,060 700,363 Jul 06 05:01 PM Burns Thomas William CHAIRMAN & CEO Jul 03 '23 Sale 69.51 26,400 1,835,041 673,963 Jul 06 05:01 PM Burns Thomas William CHAIRMAN & CEO Jun 28 '23 Option Exercise 7.28 26,810 195,043 700,773 Jun 30 06:01 PM Burns Thomas William CHAIRMAN & CEO Jun 28 '23 Sale 70.19 26,810 1,881,794 673,963 Jun 30 06:01 PM Burns Thomas William CHAIRMAN & CEO Jun 08 '23 Option Exercise 7.28 3,190 23,207 677,153 Jun 12 05:54 PM Burns Thomas William CHAIRMAN & CEO Jun 08 '23 Sale 70.02 3,190 223,364 673,963 Jun 12 05:54 PM Burns Thomas William CHAIRMAN & CEO Jun 07 '23 Option Exercise 7.28 17,382 126,454 691,345 Jun 08 06:30 PM Burns Thomas William CHAIRMAN & CEO Jun 07 '23 Sale 67.20 17,382 1,168,051 673,963 Jun 08 06:30 PM Burns Thomas William CHAIRMAN & CEO Jun 06 '23 Option Exercise 7.28 7,618 55,421 681,581 Jun 08 06:30 PM Burns Thomas William CHAIRMAN & CEO Jun 06 '23 Sale 65.04 7,618 495,475 673,963 Jun 08 06:30 PM Burns Thomas William CHAIRMAN & CEO Jun 02 '23 Option Exercise 7.28 142 1,033 674,105 Jun 05 08:09 PM Burns Thomas William CHAIRMAN & CEO Jun 02 '23 Sale 60.00 142 8,520 673,963 Jun 05 08:09 PM Burns Thomas William CHAIRMAN & CEO May 23 '23 Option Exercise 7.28 7 51 673,970 May 23 08:38 PM Burns Thomas William CHAIRMAN & CEO May 23 '23 Sale 60.00 7 420 673,963 May 23 08:38 PM Burns Thomas William CHAIRMAN & CEO May 19 '23 Option Exercise 7.28 1 7 673,964 May 23 08:38 PM Burns Thomas William CHAIRMAN & CEO May 19 '23 Sale 60.21 1 60 673,963 May 23 08:38 PM Burns Thomas William CHAIRMAN & CEO May 18 '23 Option Exercise 7.28 11,662 84,841 685,625 May 19 07:16 PM Burns Thomas William CHAIRMAN & CEO May 18 '23 Sale 60.17 11,662 701,749 673,963 May 19 07:16 PM Burns Thomas William CHAIRMAN & CEO May 17 '23 Option Exercise 7.28 620 4,510 674,583 May 19 07:16 PM Burns Thomas William CHAIRMAN & CEO May 17 '23 Sale 60.04 620 37,224 673,963 May 19 07:16 PM Burns Thomas William CHAIRMAN & CEO May 16 '23 Option Exercise 7.28 3,704 26,947 677,667 May 17 08:30 PM
Index RUT
P/E -
EPS (ttm) -1.02
Insider Own 1.67%
Shs Outstand 75.07M
Perf Week 5.44%
Market Cap 1.53B
Forward P/E -
EPS next Y -0.04
Insider Trans -1.57%
Shs Float 73.81M
Perf Month 0.94%
Income -74.40M
PEG -
EPS next Q -0.16
Inst Own 103.71%
Short Float 4.93%
Perf Quarter -18.00%
Sales 361.05M
P/S 4.23
EPS this Y 74.73%
Inst Trans 0.36%
Short Ratio 5.28
Perf Half Y -3.32%
Book/sh 14.25
P/B 1.43
EPS next Y 84.39%
ROA -6.40%
Short Interest 3.64M
Perf Year -5.39%
Cash/sh 2.88
P/C 7.06
EPS next 5Y -
ROE -7.02%
52W Range 18.61 - 30.52
Perf YTD -25.99%
Dividend Est. -
P/FCF 44.61
EPS past 5Y -10.52%
ROI -7.08%
52W High -33.29%
Beta 1.70
Dividend TTM -
Quick Ratio 4.40
Sales past 5Y 34.42%
Gross Margin 61.81%
52W Low 9.40%
ATR (14) 0.88
Dividend Ex-Date -
Current Ratio 4.66
EPS Y/Y TTM -99.73%
Oper. Margin -3.22%
RSI (14) 50.11
Volatility 4.64% 4.02%
Employees 815
Debt/Eq 0.01
Sales Y/Y TTM 21.76%
Profit Margin -20.61%
Recom 1.89
Target Price 30.83
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q -623.36%
Payout -
Rel Volume 0.44
Prev Close 20.19
Sales Surprise 6.77%
EPS Surprise -288.45%
Sales Q/Q 22.29%
Earnings May 07 AMC
Avg Volume 689.13K
Price 20.36
SMA20 2.23%
SMA50 -4.28%
SMA200 -15.46%
Trades
Volume 263,439
Change 0.84%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Reiterated
Needham
Buy
$30 → $33
Jan-18-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-05-23 Initiated
Scotiabank
Sector Outperform
$33
Jan-07-22 Initiated
Stephens
Overweight
$52
Nov-18-21 Resumed
Goldman
Buy
$60
Jun-15-21 Initiated
Raymond James
Outperform
$45
Feb-18-21 Resumed
Needham
Buy
$88
Jan-28-21 Initiated
Truist
Buy
$61
Nov-10-20 Initiated
KeyBanc Capital Markets
Sector Weight
$48
Sep-09-20 Initiated
Morgan Stanley
Underweight
$35
Jul-31-19 Initiated
Lake Street
Buy
$35
Jul-02-19 Initiated
Needham
Buy
$33
Nov-29-18 Downgrade
Janney
Buy → Neutral
Oct-31-18 Upgrade
Janney
Neutral → Buy
Nov-07-17 Downgrade
Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade
Janney
Buy → Neutral
Aug-31-17 Resumed
BTIG Research
Buy
$13
Nov-14-16 Resumed
Leerink Partners
Outperform
$12
Dec-18-15 Initiated
Cantor Fitzgerald
Buy
$13
Jun-11-15 Reiterated
Leerink Partners
Outperform
$11 → $13
Show Previous Ratings
Apr-22-24 05:00PM
08:30AM
Apr-16-24 08:30AM
Apr-02-24 10:33AM
Feb-27-24 05:55PM
03:20PM
Loading…
Feb-26-24 03:20PM
Feb-23-24 11:10AM
07:43AM
07:37AM
(Thomson Reuters StreetEvents)
Feb-22-24 06:05PM
05:03PM
(Associated Press Finance)
04:40PM
04:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
08:15AM
Loading…
Feb-06-24 08:15AM
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
(Associated Press Finance)
04:05PM
04:00PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
09:00AM
Loading…
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
08:15AM
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
04:55PM
04:05PM
Aug-01-23 08:15AM
Jul-19-23 05:00PM
Jul-08-23 08:43PM
Jun-20-23 08:31AM
Jun-12-23 08:31AM
May-30-23 06:56AM
May-25-23 05:13PM
May-24-23 09:00AM
May-23-23 05:00PM
May-22-23 07:30AM
May-12-23 06:15AM
May-05-23 01:59PM
May-04-23 06:25PM
04:05PM
09:45AM
May-03-23 05:44PM
08:30AM
May-02-23 04:05PM
May-01-23 05:35PM
Apr-29-23 04:31PM
Apr-27-23 04:05PM
10:02AM
09:55AM
Apr-18-23 09:48AM
Apr-17-23 08:30AM
Apr-13-23 05:00PM
Apr-12-23 08:30AM
Mar-23-23 06:54AM
Mar-15-23 04:15PM
11:44AM
Mar-11-23 12:11PM
Mar-10-23 09:30AM
Feb-27-23 05:00PM
Feb-24-23 05:42AM
Feb-22-23 06:15PM
04:05PM
Feb-15-23 08:36AM
Feb-13-23 05:23PM
10:14AM
Feb-06-23 05:00PM
Feb-01-23 04:05PM
08:32AM
Jan-24-23 10:23AM
Jan-23-23 09:00AM
Jan-18-23 06:10AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Dec-15-22 04:05PM
Dec-12-22 12:00PM
Dec-01-22 02:46PM
(Investor's Business Daily)
Nov-09-22 06:15AM
Nov-02-22 06:55PM
04:05PM
Nov-01-22 05:11PM
Oct-27-22 05:00PM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
EASTHAM KARIN Director Apr 01 '24 Option Exercise 13.19 10,000 131,900 43,125 Apr 02 04:17 PM EASTHAM KARIN Director Apr 01 '24 Sale 21.65 10,000 216,528 33,125 Apr 02 04:17 PM JONES EVAN/ FA Director Mar 01 '24 Option Exercise 13.19 10,000 131,900 47,601 Mar 05 05:28 PM JONES EVAN/ FA Director Mar 01 '24 Sale 24.36 10,000 243,599 37,601 Mar 05 05:28 PM JONES EVAN/ FA Director Jul 19 '23 Sale 30.17 3,090 93,232 35,173 Jul 24 05:06 PM JONES EVAN/ FA Director Jul 19 '23 Sale 30.14 838 25,257 37,601 Jul 24 05:06 PM BISHOP JOHN L Director Jul 18 '23 Option Exercise 6.37 10,000 63,700 43,125 Jul 19 08:35 PM BISHOP JOHN L Director Jul 18 '23 Sale 30.50 10,000 305,000 33,125 Jul 19 08:35 PM JONES EVAN/ FA Director Jul 18 '23 Sale 30.19 7,441 224,616 38,263 Jul 19 08:33 PM JONES EVAN/ FA Director Jul 18 '23 Sale 30.16 2,324 70,090 38,439 Jul 19 08:33 PM BISHOP JOHN L Director Jul 17 '23 Option Exercise 6.37 10,000 63,700 43,125 Jul 19 08:35 PM JONES EVAN/ FA Director Jul 17 '23 Sale 30.07 23,949 720,106 45,704 Jul 19 08:33 PM JONES EVAN/ FA Director Jul 17 '23 Sale 30.07 19,095 574,106 40,763 Jul 19 08:33 PM BISHOP JOHN L Director Jul 17 '23 Sale 30.00 10,000 300,002 33,125 Jul 19 08:35 PM Bhanji Muna Director Jun 16 '23 Sale 26.44 5,893 155,786 28,514 Jun 21 04:55 PM Bhanji Muna Director May 30 '23 Sale 25.91 1,539 39,875 24,733 Jun 01 05:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite